SEC Form 4 · accession 0001209191-15-087392
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorma Routti
Director
Period of report
Dec 28, 2015
Accepted (ET)
Dec 30, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 28, 2015 | M | 8,000 | $2.00 | A | 115,840 | D | |
| Common Stock | Dec 28, 2015 | M | 12,000 | $4.025 | A | 127,840 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $2.00 | Dec 28, 2015 | M | 8,000 | D | — | Mar 1, 2016 | Common Stock | 8,000 | 0 | D |
| Stock Option (Right to Buy)F2,F1 | $4.025 | Dec 28, 2015 | M | 12,000 | D | — | Aug 20, 2017 | Common Stock | 12,000 | 0 | D |
Explanation of responses
- F1Fully vested and exercisable.
- F2Not applicable.